Immunovant (IMVT) Short Interest Ratio & Short Volume → Log Into Marc's $5,000 System Today (From Chaikin Analytics) (Ad) Free IMVT Stock Alerts $28.42 -0.53 (-1.83%) (As of 05/28/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Immunovant Short Interest DataCurrent Short Interest9,290,000 sharesPrevious Short Interest8,960,000 sharesChange Vs. Previous Month+3.68%Dollar Volume Sold Short$287.34 millionShort Interest Ratio8.7 Days to CoverLast Record DateMay 15, 2024Outstanding Shares145,290,000 sharesFloat Size60,900,000 sharesShort Percent of Float15.25%Today's Trading Volume981,099 sharesAverage Trading Volume1,144,299 sharesToday's Volume Vs. Average86% Short Selling Immunovant ? Sign up to receive the latest short interest report for Immunovant and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartIMVT Short Interest Over TimeIMVT Days to Cover Over TimeIMVT Percentage of Float Shorted Over Time Ad Chaikin AnalyticsLog Into Marc's $5,000 System TodayNew Panic Could Sweep America Mark these words in 2024. Everyone's going to cash… Wall Street legend says: "A little-known vehicle outside of banks could double… triple… or even quadruple your life savings if you know where to find it right now." We urge you to move your cash into this vehicle in 2024. More here. Immunovant Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/15/20249,290,000 shares $287.34 million +3.7%15.3%8.7 $30.93 4/30/20248,960,000 shares $245.86 million +5.3%14.8%7.9 $27.44 4/15/20248,510,000 shares $259.30 million -5.7%14.1%7.4 $30.47 3/31/20249,020,000 shares $291.44 million -3.5%14.9%7.3 $32.31 3/15/20249,350,000 shares $285.46 million +7.7%15.3%7.1 $30.53 2/29/20248,680,000 shares $307.01 million -3.7%14.3%6.1 $35.37 Get the Latest News and Ratings for IMVT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Immunovant and its competitors with MarketBeat's FREE daily newsletter. 2/15/20249,010,000 shares $340.58 million +8.4%14.8%6 $37.80 1/31/20248,310,000 shares $302.57 million +3.4%13.7%5.5 $36.41 1/15/20248,040,000 shares $340.57 million +7.8%13.3%5.1 $42.36 12/31/20237,460,000 shares $314.29 million -2.1%12.3%4.8 $42.13 12/15/20237,620,000 shares $325.68 million +10.6%12.6%3.1 $42.74 11/30/20236,890,000 shares $269.61 million -2.4%11.4%3.1 $39.13 11/15/20237,060,000 shares $241.73 million +5.5%11.6%3.3 $34.24 10/31/20236,690,000 shares $221.10 million -0.3%14.3%3 $33.05 10/15/20236,710,000 shares $251.02 million -8.0%14.3%3.2 $37.41 9/30/20237,290,000 shares $279.86 million +42.1%15.5%3.5 $38.39 9/15/20235,130,000 shares $111.89 million +4.7%9.7%4.6 $21.81 8/31/20234,900,000 shares $111.28 million +28.6%9.3%4.3 $22.71 8/15/20233,810,000 shares $78.18 million +2.7%7.3%3.4 $20.52 7/31/20233,710,000 shares $84.70 million +3.6%7.2%3.4 $22.83 7/15/20233,580,000 shares $74.25 million -2.7%6.9%3.2 $20.74 6/30/20233,680,000 shares $69.81 million +7.6%7.1%3.5 $18.97 6/15/20233,420,000 shares $72.26 million -0.3%6.6%3.2 $21.13 5/31/20233,430,000 shares $72.06 million -20.4%6.7%3.4 $21.01 5/15/20234,310,000 shares $79.35 million -4.9%8.4%4.6 $18.41 4/30/20234,530,000 shares $73.11 million -3.6%8.8%5.2 $16.14 4/15/20234,700,000 shares $67.07 million -3.5%9.2%5.5 $14.27 3/31/20234,870,000 shares $75.53 million +21.8%9.4%5.2 $15.51 3/15/20234,000,000 shares $61.64 million +16.6%7.6%3.9 $15.41 2/28/20233,430,000 shares $59.92 million +19.9%6.6%3.2 $17.47 2/15/20232,860,000 shares $51.85 million +23.3%5.5%2.6 $18.13 1/31/20232,320,000 shares $41.23 million -4.5%4.4%2 $17.77 1/15/20232,430,000 shares $45.20 million -32.5%4.7%2.1 $18.60 12/30/20223,600,000 shares $63.90 million +27.2%7.0%3.2 $17.75 12/15/20222,830,000 shares $43.04 million +8.0%5.5%2 $15.21 11/30/20222,620,000 shares $34.35 million -9.7%5.1%2.1 $13.11 11/15/20222,900,000 shares $38.54 million +7.8%5.6%2.6 $13.29 10/31/20222,690,000 shares $30.13 million -11.2%6.2%2.5 $11.20 10/15/20223,030,000 shares $27.85 million +6.3%7.0%3.2 $9.19 9/30/20222,850,000 shares $15.90 million +7.1%6.5%3.4 $5.58Log Into Marc's $5,000 System Today (Ad)New Panic Could Sweep America Mark these words in 2024. Everyone's going to cash… Wall Street legend says: "A little-known vehicle outside of banks could double… triple… or even quadruple your life savings if you know where to find it right now." We urge you to move your cash into this vehicle in 2024. More here. 9/15/20222,660,000 shares $13.51 million +56.5%6.7%7.8 $5.08 8/31/20221,700,000 shares $8.76 million +9.0%4.3%5 $5.15 8/15/20221,560,000 shares $8.05 million -4.9%3.8%4.6 $5.16 7/31/20221,640,000 shares $6.76 million -9.9%4.0%5.2 $4.12 7/15/20221,820,000 shares $7.90 million +1.1%4.4%5.4 $4.34 6/30/20221,800,000 shares $7.02 million -13.0%4.4%4.9 $3.90 6/15/20222,070,000 shares $7.14 million -10.4%5.0%5 $3.45 5/31/20222,310,000 shares $9.79 million +0.9%5.6%4.5 $4.24 5/15/20222,290,000 shares $9.25 million -8.8%5.5%4.3 $4.04 4/30/20222,510,000 shares $11.57 million +3.3%6.1%4.3 $4.61 4/15/20222,430,000 shares $12.15 million +5.2%5.9%3.9 $5.00 3/31/20222,310,000 shares $12.73 million -17.5%5.6%3.3 $5.51 3/15/20222,800,000 shares $14.76 million -3.1%6.8%4.1 $5.27 2/28/20222,890,000 shares $16.13 million +8.2%7.1%4.2 $5.58 2/15/20222,670,000 shares $15.27 million +1.1%6.6%3.7 $5.72 1/31/20222,640,000 shares $18.45 million +2.7%6.5%3.7 $6.99 1/15/20222,570,000 shares $20.20 million +11.3%N/A0 $7.86 12/31/20212,310,000 shares $19.68 million -28.3%5.7%3.6 $8.52 12/15/20213,220,000 shares $25.34 million -5.6%8.0%5.4 $7.87 11/30/20213,410,000 shares $26.26 million +3.0%8.4%6.7 $7.70 11/15/20213,310,000 shares $27.08 million -10.8%8.2%6.1 $8.18 10/29/20213,710,000 shares $29.83 million +4.2%9.2%5.9 $8.04 10/15/20213,560,000 shares $31.04 million -1.9%8.8%3.6 $8.72 9/30/20213,630,000 shares $31.54 million -15.2%9.0%3.5 $8.69 9/15/20214,280,000 shares $36.51 million -5.5%10.6%4.1 $8.53 8/31/20214,530,000 shares $39.23 million -11.5%11.2%4.2 $8.66 8/13/20215,120,000 shares $40.35 million +9.6%18.5%3.4 $7.88 7/30/20214,670,000 shares $48.85 million +2.2%20.5%3.2 $10.46 7/15/20214,570,000 shares $46.11 million -19.8%11.5%4 $10.09 6/30/20215,700,000 shares $60.25 million +6.0%14.3%5.2 $10.57 6/15/20215,380,000 shares $57.89 million -2.9%13.5%4.8 $10.76 5/28/20215,540,000 shares $83.99 million -13.7%13.9%4.8 $15.16 5/14/20216,420,000 shares $93.80 million +11.7%16.2%5.9 $14.61 4/30/20215,750,000 shares $93.73 million No Change14.2%4.3 $16.30 4/15/20215,750,000 shares $91.51 million -10.9%14.2%3.7 $15.92 3/31/20216,450,000 shares $96.75 million +41.1%15.9%4.1 $15.00 3/15/20214,570,000 shares $77.64 million +20.3%11.1%2.9 $16.99 2/26/20213,800,000 shares $60.57 million +12.4%9.2%2.7 $15.94 2/12/20213,380,000 shares $79.40 million +34.7%8.2%3.3 $23.49 1/29/20212,510,000 shares $98.44 million -1.6%6.2%3.3 $39.22 1/15/20212,550,000 shares $113.50 million -7.3%6.3%6.1 $44.51 12/31/20202,750,000 shares $135.66 million +118.3%6.8%6.7 $49.33 12/15/20201,260,000 shares $61.66 million -8.7%3.1%3 $48.94 11/30/20201,380,000 shares $68.77 million -28.1%3.4%3.2 $49.83 11/15/20201,920,000 shares $97.29 million -18.3%4.8%3.7 $50.67 10/30/20202,350,000 shares $100.93 million -7.1%7.7%4.4 $42.95 10/15/20202,530,000 shares $105.70 million +6.8%6.9%5 $41.78 9/30/20202,370,000 shares $83.40 million +52.9%6.4%5 $35.19 9/15/20201,550,000 shares $59.95 million +31.4%4.5%3 $38.68 8/31/20201,180,000 shares $40.07 million +26.9%3.5%2.2 $33.96Log Into Marc's $5,000 System Today (Ad)New Panic Could Sweep America Mark these words in 2024. Everyone's going to cash… Wall Street legend says: "A little-known vehicle outside of banks could double… triple… or even quadruple your life savings if you know where to find it right now." We urge you to move your cash into this vehicle in 2024. More here. 8/14/2020929,700 shares $25.40 million -13.9%2.7%2 $27.32 7/31/20201,080,000 shares $24.42 million -8.5%3.1%2.5 $22.61 7/15/20201,180,000 shares $28.54 million -11.9%3.4%2.8 $24.19 6/30/20201,340,000 shares $32.63 million +205.7%5.8%3 $24.35 6/15/2020438,300 shares $11.23 million -57.5%2.4%1.2 $25.63 5/29/20201,030,000 shares $26.43 million -24.3%5.5%3.9 $25.66 5/15/20201,360,000 shares $26.33 million -11.7%7.3%5.9 $19.36 4/30/20201,540,000 shares $28.58 million +32.8%5.6%8.2 $18.56 4/15/20201,160,000 shares $20.89 million +72.5%6.0%7 $18.01 3/31/2020672,400 shares $12.78 million -17.4%3.8%4.9 $19.01 3/13/2020813,900 shares $12.65 million +8.8%16.7%7.3 $15.54 2/28/2020747,900 shares $8.23 million +6.4%15.4%5.6 $11.01 2/14/2020703,000 shares $10.59 million +5.8%14.4%4.4 $15.06 1/31/2020664,500 shares $9.85 million +48.9%13.6%3.6 $14.83 1/15/2020446,300 shares $7.01 million +41.8%9.2%2.5 $15.70 12/31/2019314,800 shares $5.06 million No Change6.5%1.9 $16.07 IMVT Short Interest - Frequently Asked Questions What is Immunovant's current short interest? Short interest is the volume of Immunovant shares that have been sold short but have not yet been covered or closed out. As of May 15th, investors have sold 9,290,000 shares of IMVT short. 15.25% of Immunovant's shares are currently sold short. Learn More on Immunovant's current short interest. What is a good short interest ratio for Immunovant? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. IMVT shares currently have a short interest ratio of 9.0. Learn More on Immunovant's short interest ratio. Which institutional investors are shorting Immunovant? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Immunovant: Walleye Trading LLC, PEAK6 Investments LLC, Twin Tree Management LP, and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Immunovant? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 15.25% of Immunovant's floating shares are currently sold short. Is Immunovant's short interest increasing or decreasing? Immunovant saw a increase in short interest in May. As of May 15th, there was short interest totaling 9,290,000 shares, an increase of 3.7% from the previous total of 8,960,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Immunovant's float size? Immunovant currently has issued a total of 145,290,000 shares. Some of Immunovant's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Immunovant currently has a public float of 60,900,000 shares. How does Immunovant's short interest compare to its competitors? 15.25% of Immunovant's shares are currently sold short. Here is how the short interest of companies compare to Immunovant: CRISPR Therapeutics AG (18.05%), ImmunityBio, Inc. (38.03%), Krystal Biotech, Inc. (9.84%), SpringWorks Therapeutics, Inc. (14.43%), Halozyme Therapeutics, Inc. (6.80%), Arcellx, Inc. (9.67%), Iovance Biotherapeutics, Inc. (22.90%), Apogee Therapeutics, Inc. (12.30%), Denali Therapeutics Inc. (8.09%), Utz Brands, Inc. (9.09%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks. What does it mean to sell short Immunovant stock? Short selling IMVT is an investing strategy that aims to generate trading profit from Immunovant as its price is falling. IMVT shares are trading down $0.53 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Immunovant? A short squeeze for Immunovant occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of IMVT, which in turn drives the price of the stock up even further. How often is Immunovant's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including IMVT, twice per month. The most recent reporting period available is May, 15 2024. More Short Interest Resources from MarketBeat Related Companies: CRISPR Therapeutics Short Interest Data ImmunityBio Short Interest Data Krystal Biotech Short Interest Data SpringWorks Therapeutics Short Interest Data Halozyme Therapeutics Short Interest Data Arcellx Short Interest Data Iovance Biotherapeutics Short Interest Data Apogee Therapeutics Short Interest Data Denali Therapeutics Short Interest Data Utz Brands Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:IMVT) was last updated on 5/28/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersDigitizing the $11T commodities sector with one tiny stockResource Stock DigestBiggest Prediction of My 50-Year Career on Wall StreetChaikin AnalyticsHe Is Giving Away BitcoinCrypto Swap ProfitsElon’s New Device is About to Shock the WorldInvestorPlaceTim Sykes’ Urgent Trade Alert: “Make this move now”Timothy SykesBitcoin’s Biggest Year YetParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Immunovant, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.